Robert A Phillips

Summary

Affiliation: University of Massachusetts Medical School
Country: USA

Publications

  1. doi request reprint Another boost for cardiac rehabilitation
    Robert A Phillips
    Heart and Vascular Center of Excellence, University of Massachusetts Memorial Medical Center, 55 Lake St N, S3 434, Worcester, MA 01655, USA
    Arch Intern Med 168:1029. 2008
  2. doi request reprint Demographic analyses of the effects of carvedilol vs metoprolol on glycemic control and insulin sensitivity in patients with type 2 diabetes and hypertension in the Glycemic Effects in Diabetes Mellitus: Carvedilol-Metoprolol Comparison in Hypertensives (
    Robert A Phillips
    University of Massachusetts Medical School, Worcester, MA, USA
    J Cardiometab Syndr 3:211-7. 2008
  3. ncbi request reprint A review of therapeutic strategies for risk reduction of recurrent stroke
    Robert A Phillips
    University of Massachusetts Medical School, University of Massachusetts Memorial Medical Center, Worcester, MA 01655, USA
    Prog Cardiovasc Dis 50:264-73. 2008
  4. doi request reprint When things go wrong: the impact of being a statistical outlier in publicly reported coronary artery bypass graft surgery mortality data
    Walter H Ettinger
    UMass Memorial Medical Center, Worcester, Massachusetts 01655, USA
    Am J Med Qual 23:90-5. 2008
  5. doi request reprint Controversies in blood pressure goal guidelines and masked hypertension
    Robert A Phillips
    University of Massachusetts Medical School, Worcester, Massachusetts, USA
    Ann N Y Acad Sci 1254:115-22. 2012
  6. doi request reprint Left ventricular hypertrophy by electrocardiography and echocardiography in the African American Study of Kidney Disease Cohort Study
    Ricardo Esquitin
    Beth Israel Deaconess Medical Center, Boston, MA, USA
    J Am Soc Hypertens 6:193-200. 2012
  7. ncbi request reprint High-risk African Americans with multiple risk factors for cardiovascular disease: challenges in prevention, diagnosis, and treatment
    Richard Allen Williams
    Department of Medicine, The David Geffen School of Medicine at UCLA, Minority Health Institute, Los Angeles, California, USA
    Ethn Dis 16:633-9. 2006
  8. ncbi request reprint Cardiovascular outcomes in the African American Study of Kidney Disease and Hypertension (AASK) Trial
    Keith Norris
    Charles R Drew University of Medicine and Science, Lynwood, CA 90262, USA
    Am J Kidney Dis 48:739-51. 2006
  9. ncbi request reprint New-onset diabetes mellitus less deadly than elevated blood pressure? Following the evidence in the administration of thiazide diuretics
    Robert A Phillips
    Arch Intern Med 166:2174-6. 2006
  10. ncbi request reprint Body weight changes with beta-blocker use: results from GEMINI
    Franz H Messerli
    St Luke s Roosevelt Hospital Center, New York City, NY 10019, USA
    Am J Med 120:610-5. 2007

Detail Information

Publications24

  1. doi request reprint Another boost for cardiac rehabilitation
    Robert A Phillips
    Heart and Vascular Center of Excellence, University of Massachusetts Memorial Medical Center, 55 Lake St N, S3 434, Worcester, MA 01655, USA
    Arch Intern Med 168:1029. 2008
  2. doi request reprint Demographic analyses of the effects of carvedilol vs metoprolol on glycemic control and insulin sensitivity in patients with type 2 diabetes and hypertension in the Glycemic Effects in Diabetes Mellitus: Carvedilol-Metoprolol Comparison in Hypertensives (
    Robert A Phillips
    University of Massachusetts Medical School, Worcester, MA, USA
    J Cardiometab Syndr 3:211-7. 2008
    ..Carvedilol effects were favorable to adjustment of age as a covariate. In hypertensive patients with diabetes, carvedilol may be a more appropriate choice when beta-blockade is indicated...
  3. ncbi request reprint A review of therapeutic strategies for risk reduction of recurrent stroke
    Robert A Phillips
    University of Massachusetts Medical School, University of Massachusetts Memorial Medical Center, Worcester, MA 01655, USA
    Prog Cardiovasc Dis 50:264-73. 2008
    ..The ongoing, large-scale, comparative Prevention Regimen for Effectively Avoiding Second Strokes (PR. FESS) trial should provide cardiologists with more definitive recommendations...
  4. doi request reprint When things go wrong: the impact of being a statistical outlier in publicly reported coronary artery bypass graft surgery mortality data
    Walter H Ettinger
    UMass Memorial Medical Center, Worcester, Massachusetts 01655, USA
    Am J Med Qual 23:90-5. 2008
    ..Several lessons were learned that may be of value to other health care organizations that experience a public crisis in clinical quality...
  5. doi request reprint Controversies in blood pressure goal guidelines and masked hypertension
    Robert A Phillips
    University of Massachusetts Medical School, Worcester, Massachusetts, USA
    Ann N Y Acad Sci 1254:115-22. 2012
    ..Masked hypertension is associated with worse outcome. Ambulatory BP monitoring for those at risk for masked hypertension needs to be incorporated into guidelines...
  6. doi request reprint Left ventricular hypertrophy by electrocardiography and echocardiography in the African American Study of Kidney Disease Cohort Study
    Ricardo Esquitin
    Beth Israel Deaconess Medical Center, Boston, MA, USA
    J Am Soc Hypertens 6:193-200. 2012
    ..0%. Consistent with findings in a general population, left ventricular hypertrophy by electrocardiography had low sensitivity and high specificity in this cohort of African Americans with hypertensive kidney disease...
  7. ncbi request reprint High-risk African Americans with multiple risk factors for cardiovascular disease: challenges in prevention, diagnosis, and treatment
    Richard Allen Williams
    Department of Medicine, The David Geffen School of Medicine at UCLA, Minority Health Institute, Los Angeles, California, USA
    Ethn Dis 16:633-9. 2006
    ..quot; The AAMRP poses clinical and public health challenges for healthcare providers. We provide clinical and public health strategies for early detection and aggressive management of AAMRP...
  8. ncbi request reprint Cardiovascular outcomes in the African American Study of Kidney Disease and Hypertension (AASK) Trial
    Keith Norris
    Charles R Drew University of Medicine and Science, Lynwood, CA 90262, USA
    Am J Kidney Dis 48:739-51. 2006
    ..Patients with chronic kidney disease are at increased risk for cardiovascular (CV) events...
  9. ncbi request reprint New-onset diabetes mellitus less deadly than elevated blood pressure? Following the evidence in the administration of thiazide diuretics
    Robert A Phillips
    Arch Intern Med 166:2174-6. 2006
  10. ncbi request reprint Body weight changes with beta-blocker use: results from GEMINI
    Franz H Messerli
    St Luke s Roosevelt Hospital Center, New York City, NY 10019, USA
    Am J Med 120:610-5. 2007
    ....
  11. ncbi request reprint Reducing the risk of stroke through appropriate targets and treatments
    Michael H Davidson
    Prev Cardiol 10:215-21. 2007
    ....
  12. ncbi request reprint Hypertensive heart disease
    Joseph A Diamond
    Division of Cardiology, Long Island Jewish Hospital, New Hyde Park, New York 10040, USA
    Hypertens Res 28:191-202. 2005
    ..The purpose of this review is to summarize current and emerging approaches to the pathophysiology and treatment of hypertensive heart disease...
  13. ncbi request reprint Quality: the need for intelligent efforts
    Lawrence Baruch
    Arch Intern Med 165:1455-6. 2005
  14. ncbi request reprint Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial
    Jackson T Wright
    Case Western Reserve University, Department of Medicine, University Hospitals of Cleveland and the Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, OH 44106 5014, USA
    JAMA 288:2421-31. 2002
    ..Hypertension is a leading cause of end-stage renal disease (ESRD) in the United States, with no known treatment to prevent progressive declines leading to ESRD...
  15. ncbi request reprint The effects of amlodipine compared to losartan in patients with mild to moderately severe hypertension
    Robert A Phillips
    Department of Medicine, Lenox Hill Hospital and New York University School of Medicine, New York, NY 10021, USA
    J Clin Hypertens (Greenwich) 5:17-23. 2003
    ....
  16. ncbi request reprint The rationale and design of the AASK cohort study
    Lawrence J Appel
    Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins Medical Institutions, Baltimore, Maryland, 21205, USA
    J Am Soc Nephrol 14:S166-72. 2003
    ..Such results might eventually lead to new strategies that delay or prevent ESRD...
  17. ncbi request reprint Regression of left ventricular hypertrophy: are there preferred drugs?
    Joseph A Diamond
    Department of Medicine, Division of Cardiology, Long Island Jewish Medical Center, 270 05 76th Avenue, New Hyde Park, NY 11040, USA
    Curr Hypertens Rep 5:368-71. 2003
    ..New avenues of research, based on combination antihypertensive therapy and on a more sophisticated understanding of the molecular mechanisms of LVH, may yield new pharmacologic approaches to regressing LV mass...
  18. ncbi request reprint Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study
    Bertram Pitt
    University of Michigan Health System, Ann Arbor, Mich, USA
    Circulation 108:1831-8. 2003
    ..This study compared LVH regression during treatment with the selective aldosterone blocker eplerenone, enalapril, and their combination in patients with hypertension...
  19. ncbi request reprint Treatment of octogenarians: should we and how
    Robert A Phillips
    Lenox Hill Hospital and New York University School of Medicine, New York, NY, USA
    J Clin Hypertens (Greenwich) 6:267-73; quiz 274-5. 2004
  20. ncbi request reprint Antihypertensive drugs and the heart
    Joseph A Diamond
    Nuclear Cardiology, Long Island Jewish Medical Center, New Hyde Park, NY 10040, USA
    Curr Cardiol Rep 6:409-15. 2004
    ..This review summarizes current and emerging approaches to the treatment of individuals with hypertensive heart disease...
  21. ncbi request reprint Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial
    George L Bakris
    Department of Preventive Medicine, Rush University Medical Center, Chicago, Ill, USA
    JAMA 292:2227-36. 2004
    ..Beta-blockers have been shown to decrease cardiovascular risk in patients with hypertension and type 2 diabetes mellitus (DM); however, some components of the metabolic syndrome are worsened by some beta-blockers...
  22. ncbi request reprint Long-term treatment with losartan versus atenolol improves insulin sensitivity in hypertension: ICARUS, a LIFE substudy
    Michael H Olsen
    Department of Clinical Physiology and Nuclear Medicine, Glostrup University Hospital, Copenhagen, Denmark
    J Hypertens 23:891-8. 2005
    ..We hypothesized that treatment with losartan as compared to atenolol would improve insulin sensitivity through regression of peripheral vascular hypertrophy/rarefaction...
  23. ncbi request reprint Screening for depression: this is the heart of the matter
    Grant R Grissom
    Arch Intern Med 165:1214-6. 2005
  24. ncbi request reprint Hypertensive emergencies: diagnosis and management
    Robert A Phillips
    Departmnet of Medicine, Lenox Hill Hospital, NYU School of Medicine, New York, NY 10021, USA
    Prog Cardiovasc Dis 45:33-48. 2002
    ..Strategy is supported by evidence-based considerations whenever possible. Where outcome studies are not available, we rely on the rationale derived from relevant clinical research...